APYX 8-K 2026-11-05

Apyx Medical Corp (APYX) 8-K dated 2026-11-05 — accession 0001437749-26-035079.

Apyx Medical Corp (APYX) is a medical devices company listed on US.

Apyx Medical Corp filed a 8-K on 2026-11-05. Accession 0001437749-26-035079.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported APYX revenue for 2025-12-31 was $52.8M. Net income was -$11.2M. Revenue was up 9.9% from 2024-12-31 to 2025-12-31. APYX currently screens at market cap $179.6M.

Not investment advice. The APYX SEC hub lists recent forms. The stock page is the research view.